GR1006148B - Αναβραζοντα δισκια και αναβραζοντα κοκκια που περιεχουν τρυγικη καρνιτινη - Google Patents

Αναβραζοντα δισκια και αναβραζοντα κοκκια που περιεχουν τρυγικη καρνιτινη

Info

Publication number
GR1006148B
GR1006148B GR20070100742A GR20070100742A GR1006148B GR 1006148 B GR1006148 B GR 1006148B GR 20070100742 A GR20070100742 A GR 20070100742A GR 20070100742 A GR20070100742 A GR 20070100742A GR 1006148 B GR1006148 B GR 1006148B
Authority
GR
Greece
Prior art keywords
effervescent
carnitine tartrate
granules
tablets
contain carnitine
Prior art date
Application number
GR20070100742A
Other languages
English (en)
Inventor
Κλεων Τσετης
Original Assignee
Uni-Pharma Κλεων Τσετης, Φαρμακευτικα Εργαστηρια Αβεε
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni-Pharma Κλεων Τσετης, Φαρμακευτικα Εργαστηρια Αβεε filed Critical Uni-Pharma Κλεων Τσετης, Φαρμακευτικα Εργαστηρια Αβεε
Priority to GR20070100742A priority Critical patent/GR1006148B/el
Publication of GR1006148B publication Critical patent/GR1006148B/el
Priority to ES08856371T priority patent/ES2401402T3/es
Priority to PT88563713T priority patent/PT2227221E/pt
Priority to EP08856371A priority patent/EP2227221B1/en
Priority to PL08856371T priority patent/PL2227221T3/pl
Priority to PCT/GR2008/000069 priority patent/WO2009071954A1/en
Priority to DK08856371.3T priority patent/DK2227221T3/da
Priority to HRP20130196AT priority patent/HRP20130196T1/hr
Priority to SI200830905T priority patent/SI2227221T1/sl
Priority to CY20131100226T priority patent/CY1113804T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η παρούσα εφεύρεση έχει σχέση με τις φαρμακοτεχνικές μορφές της L-Καρνιτίνης που έχουν ως δραστικό συστατικό την L-Καρνιτίνη με τη μορφή Τρυγικού άλατος.
GR20070100742A 2007-12-07 2007-12-07 Αναβραζοντα δισκια και αναβραζοντα κοκκια που περιεχουν τρυγικη καρνιτινη GR1006148B (el)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GR20070100742A GR1006148B (el) 2007-12-07 2007-12-07 Αναβραζοντα δισκια και αναβραζοντα κοκκια που περιεχουν τρυγικη καρνιτινη
ES08856371T ES2401402T3 (es) 2007-12-07 2008-12-05 Comprimidos efervescentes y gránulos efervescentes que contienen tartrato de carnitina
PT88563713T PT2227221E (pt) 2007-12-07 2008-12-05 Comprimidos efervescentes e grânulos efervescentes contendo tartarato de carnitina
EP08856371A EP2227221B1 (en) 2007-12-07 2008-12-05 Effervescent tablets and effervescent granules containing carnitine tartrate
PL08856371T PL2227221T3 (pl) 2007-12-07 2008-12-05 Tabletki musujące i granulki musujące zawierające winian karnityny
PCT/GR2008/000069 WO2009071954A1 (en) 2007-12-07 2008-12-05 Effervescent tablets and effervescent granules containing carnitine tartrate
DK08856371.3T DK2227221T3 (da) 2007-12-07 2008-12-05 Brusetabletter og brusepulvere indeholdende carnitintartrat
HRP20130196AT HRP20130196T1 (hr) 2007-12-07 2008-12-05 Šumeä†e tablete i šumeä†e granule koje sadrže karnitin tartarat
SI200830905T SI2227221T1 (sl) 2007-12-07 2008-12-05 Ĺ umeäśe tablete in ĺ umeäśe granule, ki vsebujejo karnitin tartrat
CY20131100226T CY1113804T1 (el) 2007-12-07 2013-03-15 Αναβραζοντα δισκια και αναβραζοντες κοκκοι που περιεχουν τρυγικη καρνιτινη

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20070100742A GR1006148B (el) 2007-12-07 2007-12-07 Αναβραζοντα δισκια και αναβραζοντα κοκκια που περιεχουν τρυγικη καρνιτινη

Publications (1)

Publication Number Publication Date
GR1006148B true GR1006148B (el) 2008-11-10

Family

ID=40229652

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20070100742A GR1006148B (el) 2007-12-07 2007-12-07 Αναβραζοντα δισκια και αναβραζοντα κοκκια που περιεχουν τρυγικη καρνιτινη

Country Status (10)

Country Link
EP (1) EP2227221B1 (el)
CY (1) CY1113804T1 (el)
DK (1) DK2227221T3 (el)
ES (1) ES2401402T3 (el)
GR (1) GR1006148B (el)
HR (1) HRP20130196T1 (el)
PL (1) PL2227221T3 (el)
PT (1) PT2227221E (el)
SI (1) SI2227221T1 (el)
WO (1) WO2009071954A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009356961B2 (en) * 2009-12-14 2016-05-19 Jubilent Global Limited Effervescent L-carnitine-based composition
TW201416094A (zh) * 2012-10-31 2014-05-01 Genebio Biotech Co Ltd 具左旋肉鹼之發泡錠與製作方法
CA3018828C (en) 2014-09-17 2021-05-11 Steerlife India Private Limited Effervescent composition and method of making it
WO2017098481A1 (en) * 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
CN111990574A (zh) * 2020-09-18 2020-11-27 内蒙古精晶生物科技有限公司 一种左旋肉碱营养泡腾片

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635864A1 (de) * 1986-06-26 1988-05-05 Gerhard Gergely Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
US5073376A (en) * 1989-12-22 1991-12-17 Lonza Ltd. Preparations containing l-carnitine
US5560928A (en) * 1995-06-23 1996-10-01 Defelice; Stephen L. Nutritional and/or dietary composition and method of using the same

Also Published As

Publication number Publication date
EP2227221B1 (en) 2013-02-13
WO2009071954A1 (en) 2009-06-11
HRP20130196T1 (hr) 2013-04-30
EP2227221A1 (en) 2010-09-15
DK2227221T3 (da) 2013-03-25
SI2227221T1 (sl) 2013-05-31
PL2227221T3 (pl) 2013-06-28
PT2227221E (pt) 2013-03-28
ES2401402T3 (es) 2013-04-19
CY1113804T1 (el) 2016-07-27

Similar Documents

Publication Publication Date Title
UA103915C2 (ru) Твердая лекарственная форма, которая содержит линаглиптин и ингибитор sglt2, и ее применение
WO2013066839A3 (en) Compounds and methods
WO2013066835A3 (en) Compounds and methods
WO2012020131A3 (en) Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
IN2013CN01340A (el)
MX2011008634A (es) Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia.
IN2012DN01435A (el)
MY156434A (en) Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
EA201300053A1 (ru) Фосфатсвязывающий препарат для удобного приема
MY148948A (en) Catecholamine derivatives and prodrugs thereof
BRPI0908052A2 (pt) Composições farmacêuticas de entacapone, levodopa e carbidopa com biodisponibilidade melhorada
PH12012502083A1 (en) Manufacturing of active-free granules and tablets comprising the same
MX2014006004A (es) Derivados de aminobenzociclohepteno, aminotetralina, aminoindano y fenalcilamina n-sustituidas, composiciones farmaceuticas que los contienen, y su uso en terapia.
MX2015001917A (es) Composiciones farmaceuticas de memantina.
MX2011013440A (es) Composiciones farmaceuticas novedosas que contienen pregabalina.
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
GR1006148B (el) Αναβραζοντα δισκια και αναβραζοντα κοκκια που περιεχουν τρυγικη καρνιτινη
SG10201501579WA (en) Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
MX336333B (es) Nueva forma cristalina de un derivado de ciclopropilbenzamida.
WO2014144407A8 (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
UY31662A1 (es) Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de elaboracion.
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
TR200909786A1 (tr) Sefiksim içeren efervesan tablet ve granül formülasyonu.

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20140702